1 p.m. - 2 p.m.
Webinar Registration here
This session is open to doctors and healthcare professionals only.
CME points will be awarded.
Most recently, molecular diagnostics have played a vital role in the global health response to the COVID-19 pandemic. Let’s talk about how best to use newer evidence-based molecular tests for LRTI, combined with clinical judgment and traditional methods in the real-world setting.
Dr. Kong Po Marn
Dr. Kong Po Marn graduated from the National University of Singapore (1989), he obtained membership of the Royal College of Physicians (UK) in 1994 and MMed (Int Med) in 1995. He trained in respiratory medicine at TTSH and subsequently spent one year at the National Jewish Health in Colorado (USA) where he focused on patients with difficult asthma and mycobacterial infections under the Health Manpower Development Plan fellowship.
Dr. Kong is a chest physician with extensive experience. Prior to private practice, he was with Tan Tock Seng Hospital (TTSH), where he set up the Non-Tuberculous Mycobacteria (NTM) clinic while taking charge of the Occupational Lung Diseases clinic. He remains as visiting consultant to the Department of Respiratory Medicine.
He has published in international journals and has lectured frequently on Asthma and Lung Diseases. He is currently a Fellow of the Academy of Medicine in Singapore, Fellow of the Royal College of Physicians of Edinburgh as well as a member of the American Thoracic Society, and has held the appointment of President of the Singapore Thoracic Society (2004).
Dr. Satheesh Thangaraj
Head - Medical Affairs in bioMérieux (ASEAN)
Dr. Satheesh Thangaraj holds M.Sc and Ph.D in Medical Microbiology and has 25 years of working experience in Clinical Microbiology domain. Specific field of interests are diagnostic clinical microbiology, molecular diagnosis of infectious diseases, Antimicrobial resistance, critical infectious diseases such as Tuberculosis, Sepsis and B cell immune response in TB.
Presently is Head of Medical affairs department in bioMérieux for ASEAN countries. He leads medical affairs programs such as field clinical studies, medical education programs, young investigator award programs, point prevalence surveys, etc.
Started his career in Dept of Clinical Microbiology, Christian Medical College & Hospital as research associate and worked on prevalence of S.pneumomiae and H.influenzae, incidence of MRSA, etc. Later at Dr. Reddys Laboratories Ltd, lead developmental projects for diagnosis of infectious diseases. Also worked on the product development and clinical trial for phage based diagnostic method for Mycobacterium tuberculosis.
Joined bioMerieux in the year of 2000 and held various positions in scientific support, research project management and medical affairs. Deputed to R&D Dept, bioMerieux Sa, France, for two years to develop Immunoassay based diagnostic test for Tuberculosis. Later managed a multi centric field study on methods for Tuberculosis diagnosis in India jointly conducted by ICMR and Foundation Mérieux. Also consulted and coordinated for projects in Tuberculosis and HIV-TB Coinfection for National CDC, Beijing. Later, he lead a collaborative research project between Institute Mérieux and A*STAR of Singapore in identifying genomic biomarkers for Tuberculosis.
Published in peer reviewed journals in the field of tuberculosis and bacterial antibiotic resistance. Member of Indian association of Medical Microbiologist, European Society of clinical Microbiologist and Infectious Diseases (ESCMID) and Singapore Society for Microbiology and Biotechnology (SSMB).